Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3505650

Documents

Beta release

Statistics of Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial)
Statistics for this year
PeriodVisitsDownloads
202499
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0911
2024-1022
2024-1100